Noble Corporation(NYSE:NE) is scheduled to report earnings today with analyst looking for $2.14
Noble Corp. is a leading provider of diversified services for the oil and gas industry. Contract drilling services are performed with the company''s fleet of offshore drilling units located in key marketsworldwide. The company''s fleet of floating deepwater units consists of nine semisubmersibles and three dynamically positioned drillships, seven of which are designed to operate in water depths greater than 5,000 feet.(Press Release)
NE last traded at $98.87
Technical Data:
Resistance: 103.26
Support: 97.66
MACD: -0.17
RSI14: 58.02
ATR10: 2.36
MA200: 79.00
Earnings Estimates
Current Estimates: $2.15
Number of Estimates: 21
High Estimate: $2.29
Low Estimate: $1.95
Last Year EPS: $1.32
Percentage Growth: 63.00 %
IMS Health Incorporated(NYSE:RX) is scheduled to report earnings today with analyst looking for $0.39
IMS Health is the global provider of information solutions to the pharmaceutical and healthcare industries. IMS Health consists of: the IMS segment, which consists of the market information and decision-support services business for the pharmaceutical and healthcare industries conducted by IMS Health and IMS Health Strategic Technologies, Emerging Markets, and a majority ownership interest in Cognizant Technology Solutions Corporation.
RX last traded at $32.16
Technical Data:
Resistance: 33.10
Support: 32.42
MACD: 0.02
RSI14: 56.67
ATR10: 0.50
MA200: 29.26
Earnings Estimates
Current Estimates: $0.39
Number of Estimates: 9
High Estimate: $0.41
Low Estimate: $0.37
Last Year EPS: $0.32
Percentage Growth: 22.00 %
SurModics, Inc.(NASDAQ:SRDX) is scheduled to report earnings today with analyst looking for $0.34
SurModics, Inc. is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics. SurModics partners with the world''s foremost medical device, pharmaceutical and life science companies to bring innovation together for better patient outcomes. Recent collaborative efforts include the implementation of SurModics'' Bravo drug delivery polymer matrix as a key component of the first-to-market drug-eluting coronary stent. SurModics is also active in the ophthalmology market with a sustained drug delivery system that is currently in human trials for treatment of retinal disease. A significant portion of SurModics'' revenue is generated by royalties earned from the sale of our customers'' commercial products.
SRDX last traded at $47.42
Technical Data:
Resistance: 50.63
Support: 47.01
MACD: -0.01
RSI14: 61.92
ATR10: 1.69
MA200: 36.44
Earnings Estimates
Current Estimates: $0.34
Number of Estimates: 3
High Estimate: $0.37
Low Estimate: $0.32
Last Year EPS: $0.34
Percentage Growth: 1.00 %
Texas Capital Bancshares, Inc.(NASDAQ:TCBI) is scheduled to report earnings today with analyst looking for $0.31
Texas Capital Bancshares'' primary subsidiary is Texas Capital Bank, a commercial bank that delivers highly personalized financial services to Texas-based businesses and private client individuals.
